Please login to the form below

Market Access Transformation

Founded in 201, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange insights that asses the real-world potential of their pharmaceutical products. With close to 65 employees that span the US, UK and India, MAT is seen as a revolutionary company in the global pharmaceutical research space.

Our primary platform, Rapid Payer Responses™ (RPR), enables pharmaceutical manufacturers to conduct critical market access research throughout the product and treatment development process. Through our global, vetted payer network, it is possible to gather more accurate, robust feedback and insights by probing further and asking deeper questions. you always have the exact answers you need in a fraction of the time and cost of a traditional payer research project. Our life science experts help facilitate this process, monitoring the responses in real time as they come in for quality and detail.

Since the launch of Rapid Payer Response™ (RPR) in July 2016, we have partnered with over 50 of the leading pharmaceutical manufacturers, expanded our payer network to more than 45 countries and have achieved an impressive 93% license renewal rate as we continue to disrupt the older and outdated models for payer research.

Areas of Expertise

Rapid Payer Response specializes in creating new technologies that allow pharmaceutical companies and manufacturers get feedback and insight on demand from a network of global, expert payers. In as little as 5 days, a research team can have detailed answers to their most pressing questions. It is much quicker and more cost effective than traditional payer research projects.

Clients

  • Amgen
  • Bristol Myers Squibb
  • Gilead
  • GSK
  • Janssen (J&J)
  • Jazz
  • Novo Nordisk
  • Pfizer
  • Astellas
  • Boehringer Ingelheim
  • Daiichi-Sankyo
  • Eisai
  • EMD Serono
  • Novartis
  • Roche
  • Sanofi
  • Teva
  • Merck
  • UCB and more

Team

Baiju Aurora
Baiju Aurora
CEO, Founder and Chairman of the Board
baurora@marketaccesstransformation.com
View LinkedIn profile
Kuldeep Singh
Director And Head Of Global Market Access Operations
ksingh@marketaccesstransformation.com
View LinkedIn profile
Martin Hannon
Director of Technology
mhannon@marketaccesstransformation.com
View LinkedIn profile
Kristen Beveridge
VP, Global Brand & Marketing
kbeveridge@marketaccesstransformation.com
View LinkedIn profile
Greg Rouse
Director, Global Commercial Development
grouse@marketaccesstransformation.com
View LinkedIn profile
Aji Barot
Director, Global Commercial Development
abarot@marketaccesstransformation.com
View LinkedIn profile
Edward Ingham
Senior Manager, Global Commercial Development
eingham@marketaccesstransformation.com
View LinkedIn profile
Nick DeJesus
Director, Global Commercial Development
ndejesus@marketaccesstransformation.com
View LinkedIn profile
 

Press Releases

Market Access Transformation (MAT) Secures First Institutional Funding Led by Silversmith Capital Partners

MAT is excited to officially announce a minority investment from Silversmith Capital Partners.

White Papers and Resources

Robust Review: Surrogate Endpoints

See how our client utilized Rapid Payer Response™ (RPR) to gain invaluable payer insight and understanding of the acceptability and importance of surrogate end-points for their product…In 3 Weeks not 5 Months!

Robust Review: Clinical Trial Design

See how our client utilized Rapid Payer Response™ (RPR) to gain invaluable payer insight to develop the optimal clinical trial for their product…In 3 Weeks not 5 Months!

Robust Review: Multi-Indication Prioritization

See how our client leveraged Rapid Payer Response™ (RPR) to prioritize their asset's commercial opportunity across multiple indications in Acute Lymphoblastic Leukemia (ALL)… And got their Insights Report delivered in just 3 weeks!

Robust Review: Vetting Evidence Generation Plan

See how our client utilized Rapid Payer Response™ (RPR) to gain invaluable payer insight into their TPP and the design of their evidence generation plan…in 3 Weeks!

Robust Review: Pricing & Market Access

See how our client utilized Rapid Payer Response™ (RPR) to gain invaluable Payer insight into the Pricing and Market Access acceptability of their novel product within 3 Weeks.

Robust Review: COVID19 Assessment

See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)

Videos and Podcasts

Facebook

Testimonials

I am responsible for early stage oncology assets in an environment that is constantly changing, so I find it very comforting to know that I can reach out to payers in an on-demand fashion

– Global Payer Lead Oncology

This makes a great deal of sense and I really appreciate your experience and judgment to be able to comment like this. You have definitely confirmed what I suspected but you have really added richness in your comments.

– Oncology Access Director

The qualitative quotes are helpful in adding color; the frameworks, effective in organizing various dimensions assessed. MAT team demonstrated thorough understanding and familiarity with the topic and research and expertly addressed audience questions. The insights generated are directive and much appreciated.

– Associate Director, Global Access

Many thanks in helping push this through: the feedback call with management paid high praise on responsiveness and questionnaire development! They said the quality of the work makes his boss, happy and that there is nothing more they could ask for!

– Director, Global Market Access

Company Details

Market Access Transformation

917 913 2009

Contact Website

Address:
51 John F Kennedy Parkway
1st Floor West
Short Hills
New jersey
07078
USA

Latest content on this profile

Robust Review: Surrogate Endpoints
See how our client utilized Rapid Payer Response™ (RPR) to gain invaluable payer insight and understanding of the acceptability and importance of surrogate end-points for their product…In 3 Weeks not 5 Months!
Market Access Transformation
Robust Review: Clinical Trial Design
See how our client utilized Rapid Payer Response™ (RPR) to gain invaluable payer insight to develop the optimal clinical trial for their product…In 3 Weeks not 5 Months!
Market Access Transformation
Robust Review: Multi-Indication Prioritization
See how our client leveraged Rapid Payer Response™ (RPR) to prioritize their asset's commercial opportunity across multiple indications in Acute Lymphoblastic Leukemia (ALL)… And got their Insights Report delivered in just 3 weeks!
Market Access Transformation
Robust Review: Vetting Evidence Generation Plan
See how our client utilized Rapid Payer Response™ (RPR) to gain invaluable payer insight into their TPP and the design of their evidence generation plan…in 3 Weeks!
Market Access Transformation
Robust Review: Pricing & Market Access
See how our client utilized Rapid Payer Response™ (RPR) to gain invaluable Payer insight into the Pricing and Market Access acceptability of their novel product within 3 Weeks.
Market Access Transformation
Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)
Market Access Transformation